_immunomodulators-part-2-immunostimulants-preview-1.jpg "Immunomodulators Part 2: Immunostimulants from immunomodulatory therapy Video Screenshot Preview 1")
Gallery_immunomodulators-part-2-immunostimulants-preview-3.jpg "Immunomodulators Part 2: Immunostimulants from immunomodulatory therapy Video Screenshot Preview 3")
Gallery_immunomodulators-part-2-immunostimulants-preview-hqdefault.jpg "Immunomodulators Part 2: Immunostimulants from immunomodulatory therapy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 5 minutes 27 seconds
👁 View: 12K times
Play Audio:👁 View: 12K times
Description:
Professor Dave Explains
Professor Dave Explains
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_immunomodulatory-drugs.webp "Myeloma UK")
_treating-ibd-immunomodulators.webp "Crohn's u0026 Colitis Foundation")
_ido1-indoleamine-23-dioxygenase.webp "IDO1 is an immunosuppressive enzyme that leads to regulatory T-cell generation and activation, and allows tumors to escape from immune surveillance.nnInhibition of immunomodulatory mechanisms with IDO1 inhibitor-based combination therapy may re-establish anti-tumor immunity.")
_the-imsavar-project-making-immunomodulatory-therapies-safer.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_what-should-you-know-about-myeloma-treatment-options.webp "Dr. Peter Forsberg outlines options in the myeloma treatment toolkit, including targeted therapies, chemotherapy, immunotherapy, and combination approaches —and explains how the recovery process from stem cell transplant has improved.nnDr. Peter Forsberg is assistant professor of medicine at the University of Colorado School of Medicine and is a specialist in multiple myeloma. More about Dr. Forsberg here: https://www.cudoctors.com/Find_A_Doctor/Profile/24672.")
_pharmacology-immune-system-drugs-full-video-nursing-rn-pn-nclex.webp "Simple Nursing")
_pharmacology-immunosuppressants-made-easy.webp "Speed Pharmacology")
_at-100-recombinant-human-surfactant-protein-d.webp "AT-100 is a recombinant form of human surfactant protein-D (rhSP-D). SP-D, absent from current therapies, is a normal protein component of lung surfactant that performs three critical roles in maintaining healthy lung function.nn1. Surfactant Homeostasisn2. Immunomodulatoryn3. Anti-inflammatorynnAT-100 augments current therapy:n- Current therapy is commercial lung surfactant—40% of very low birth weight babies don’t respond to this therapyn- AT-100 adds back the missing surfactant protein-Dn")
_immunomodulatory-drugs.jpg)
_treating-ibd-immunomodulators.jpg)
_ido1-indoleamine-23-dioxygenase.jpg)
_the-imsavar-project-making-immunomodulatory-therapies-safer.jpg)
_what-should-you-know-about-myeloma-treatment-options.jpg)
_pharmacology-immune-system-drugs-full-video-nursing-rn-pn-nclex.jpg)
_pharmacology-immunosuppressants-made-easy.jpg)
_at-100-recombinant-human-surfactant-protein-d.jpg)
![[+]](/images/menu.gif){kind=small}